Related Experiment Video
Updated: Mar 27, 2026

10:08
Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
Published on: August 28, 2012
12.3K
Stabilizing Off-pathway Oligomers by Polyphenol Nanoassemblies for IAPP Aggregation Inhibition
Praveen Nedumpully-Govindan1, Aleksandr Kakinen2, Emily H Pilkington2
1Department of Physics and Astronomy, Clemson University, Clemson, SC 29634, USA.
Scientific Reports
|January 15, 2016
Summary
Polyphenols like curcumin and resveratrol prevent islet amyloid polypeptide (IAPP) aggregation by stabilizing small oligomers. This discovery offers a new mechanism for developing anti-amyloid therapeutics.
Area of Science:
- Biochemistry
- Computational Biology
- Materials Science
Background:
- Naturally occurring polyphenols exhibit protein aggregation inhibitory effects.
- Islet amyloid polypeptide (IAPP), also known as amylin, is implicated in protein aggregation disorders.
Purpose of the Study:
- To investigate the anti-aggregation effects of curcumin and resveratrol on IAPP.
- To elucidate the molecular mechanisms underlying polyphenol-mediated IAPP aggregation inhibition.
Main Methods:
- Discrete Molecular Dynamics (DMD) simulations were employed to model IAPP aggregation.
- High-throughput Dynamic Light Scattering (DLS) experiments were conducted to validate simulation findings.
Main Results:
- DMD simulations revealed that polyphenols stabilize small molecular weight IAPP off-pathway oligomers.
- Hydrogen bonds, π-π stacking, and hydrophobic interactions mediate IAPP-polyphenol stabilization.
- DLS confirmed the presence of stable, nanometer-sized oligomers for up to 7.5 hours.
Conclusions:
- Polyphenols, including curcumin and resveratrol, exhibit significant anti-aggregation effects on IAPP.
- A general anti-aggregation mechanism involving oligomer stabilization by polyphenols was proposed.
- The study provides a computational framework for designing novel anti-amyloid aggregation therapeutics.
Related Concept Videos
Drugs that Stabilize Microtubules
2.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Drugs that Destabilize Microtubules
4.3K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.3K
Site-Targeted Drug Delivery Systems: Polymeric Carriers
109
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
109

